Genome-wide association studies of cerebral white matter lesions indicate that WBP2 gene is high risk for leukoaraiosis, suggesting that WBP2 might be a key regulator of nervous system inflammation16. This evidence concerns the gene WBP2 and Abnormal cerebral white matter morphology.